CENGILD | CENGILD MEDICAL BERHAD
0.225 (-2.17%)
T-O (am): 0.000 (08:59:00)
Last updated: 11:54
Fundamental
Technical
Total Score
CENGILD Fundamental Trend
FCON: | Sharpe Ratio: | LTS:
CENGILD Quarter Reports
Customize
Select columns required and click "Update" to save your preferences
| Ann. Date | Qtr. Date | Q | FYE | Revenue [M] | PBT [M] | NP [M] | NPM | DPS | EPS | R. QoQ | R. YoY | E. QoQ | E. YoY | TTM EPS |
Adj. [M] |
NP [M] (adj) |
NPM (adj) |
EPS (adj) |
E. QoQ (adj) |
E. YoY (adj) |
TTM EPS (adj) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24 Nov 25 | Q1 Sep 2025 | 1 | 30 Jun 2026 | 18.67 | 3.84 | 2.92 | 15.6% | 0.00 | 0.35 | 4.2% | 16.2% | 32.1% | 27.1% | ||||||||
| 29 Aug 25 | Q4 Jun 2025 | 4 | 30 Jun 2025 | 19.48 | 3.37 | 2.21 | 11.3% | 0.37 | 0.27 | 5.1% | 20.7% | 15.9% | 45.2% | ||||||||
| 29 May 25 | Q3 Mar 2025 | 3 | 30 Jun 2025 | 18.53 | 3.26 | 1.91 | 10.3% | 0.00 | 0.23 | 8.2% | 8.7% | 35.3% | 37.3% | ||||||||
| 24 Jan 25 | Q2 Dec 2024 | 2 | 30 Jun 2025 | 20.18 | 4.06 | 2.94 | 14.6% | 0.60 | 0.35 | 9.5% | 25.7% | 26.4% | 0.8% | ||||||||
| 25 Nov 24 | Q1 Sep 2024 | 1 | 30 Jun 2025 | 22.29 | 5.66 | 4.00 | 17.9% | 0.00 | 0.48 | 38.1% | 26.6% | 163.1% | 11.2% | ||||||||
| 27 Aug 24 | Q4 Jun 2024 | 4 | 30 Jun 2024 | 16.14 | 2.71 | 1.52 | 9.4% | 0.37 | 0.18 | 5.3% | 2.4% | 50.0% | 32.0% | ||||||||
| 28 May 24 | Q3 Mar 2024 | 3 | 30 Jun 2024 | 17.05 | 4.41 | 3.04 | 17.8% | 0.00 | 0.37 | 6.2% | 3.5% | 4.0% | 6.6% | ||||||||
| 27 Feb 24 | Q2 Dec 2023 | 2 | 30 Jun 2024 | 16.05 | 4.00 | 2.92 | 18.2% | 0.37 | 0.35 | 8.8% | 16.5% | 18.8% | 30.0% | ||||||||
| 24 Nov 23 | Q1 Sep 2023 | 1 | 30 Jun 2024 | 17.60 | 4.74 | 3.60 | 20.4% | 0.00 | 0.43 | 11.6% | 0.1% | 60.8% | 0.5% | ||||||||
| 24 Aug 23 | Q4 Jun 2023 | 4 | 30 Jun 2023 | 15.77 | 2.67 | 2.24 | 14.2% | 0.37 | 0.27 | 10.8% | 8.0% | 31.3% | 41.3% | ||||||||
| 30 May 23 | Q3 Mar 2023 | 3 | 30 Jun 2023 | 17.67 | 4.40 | 3.26 | 18.4% | 0.00 | 0.40 | 8.1% | 11.9% | 22.1% | 84.0% | ||||||||
| 28 Feb 23 | Q2 Dec 2022 | 2 | 30 Jun 2023 | 19.22 | 5.42 | 4.18 | 21.7% | 0.37 | 0.51 | 9.1% | 14.2% | 15.5% | 71.5% | ||||||||
| 25 Nov 22 | Q1 Sep 2022 | 1 | 30 Jun 2023 | 17.62 | 4.88 | 3.62 | 20.5% | 0.00 | 0.44 | 2.8% | 5.1% | ||||||||||
| 25 Aug 22 | Q4 Jun 2022 | 4 | 30 Jun 2022 | 17.14 | 3.37 | 3.81 | 22.2% | 0.37 | 0.49 | 8.5% | 115.3% | ||||||||||
| 26 May 22 | Q3 Mar 2022 | 3 | 30 Jun 2022 | 15.79 | 3.13 | 1.77 | 11.2% | 0.00 | 0.30 | 6.2% | 27.3% | ||||||||||
| 30 Mar 22 | Q2 Dec 2021 | 2 | 30 Jun 2022 | 16.83 | 3.34 | 2.44 | 14.5% | 0.00 | 0.41 |
CENGILD Historical Dividends
CENGILD Financial Ratios
| EPS | 1.2 sen |
| Trailing PE (Sector Median: 26.5) | 19.1 |
| PEG | 3.8 |
| Altman Z | 1.1 |
| Beaver | 0.091 |
| Current Ratio | 3.71 |
| Debt-Equity (DE) Ratio | 0.73 |
| FCF Yield | -8.48 % |
| Revenue QoQ | -4.17 % |
| Revenue YoY | -16.24% |
| Profit QoQ | 32.1 % |
| Profit YoY | -27.07 % |
| Profit Margin (Sector Median: 7.6) | 12.98 % |
| ROE (ROIC: 5.87) | 8.73 % |
| Dividend Per Share (DPS) | 0.97 sen |
| Dividend Yield (DY) | 4.22 % |
CENGILD Adjusted Financial Ratios
Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports
| EPS | |
| Trailing PE (Sector Median: 26.5) | |
| Profit QoQ | |
| Profit YoY | |
| Profit Margin (Sector Median: 7.6) | |
| ROE (ROIC: 7.01) | |
| Altman Z |
CENGILD Fair Value
Weighted Average Fair Value:
| Discounted Cash Flow (DCF) 5% Growth | |
| Discounted Cash Flow (DCF) 10% Growth | |
| Relative Valuation |
| Graham Formula | |
| Graham Number | |
| Net Tangible Asset (NTA) | 0.14 | Consistent QR FV |
The Fair Value numbers are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The figures shown here should be taken as educational purposes only
Advanced Calculators
Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.
| Forward PE FV Calculator | |
| Latest Profit (adjusted) [M] | 2.92 |
| Expected Profit (Next QR) [M] | |
| Expected Profit (After QR above) [M] | |
| Expected Profit (After QR above) [M] | |
| Estimated Fair Value |
| Growth/Risk Fair Value Calculator | |
| Expected growth (%) | |
| Estimated downside / risk (%) | |
| Estimated New DCF Fair Value |
| Contract/Award Contribution Calculator | |
| Contract/Award Value (in Million) | |
| Estimated Contribution to Stock Price | |
| Estimated New DCF Fair Value |
| Profit-Based Calculator | |
| Expected Profit (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Revenue-Based Calculator | |
| Expected Revenue (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Market Pricing | |
| Expected Profit (M) | 0 |
| Expected Revenue (M) | 0 |
| Expected Growth (%) | 0 |
The Fair Value calculated using this calculators are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The purpose of this tool is to help investor to quickly calculate their own expected Fair Value based on their own research
CENGILD Directors Share Purchases (Beta)
DR CHONG SU-LIN reduced 100000.0 units announced on 09 Jan 2023 at ~RM0.49
CENGILD Summary
Market Cap: 191 M.
Market Cap Class: Micro caps
Number of Shares: 832 M.
Adjusted Float: 60.2%.
Stock highly correlated with
ECA (95%)
BINACOM (90%)
PRG (90%)
ASTRO (89%)
Cengild Medical Berhad, incorporated in 2021 and headquartered in Kuala Lumpur, Malaysia, specializes in gastrointestinal and liver disease care, with a strong focus on obesity management and related specialties. Operating through its flagship Cengild G.I. Medical Centre, the company offers a wide range of services including gastroenterology, hepatology, gastrointestinal surgery, bariatric surgery, oncology, cardiology, urology, and ENT. It also provides diagnostic imaging, 24-hour emergency care, laboratory services, and outpatient treatments supported by multidisciplinary medical teams. Cengild’s operations are anchored by two main business segments, Consultant Services and Medical Management Services which delivered through state-of-the-art facilities, complemented by satellite primary care clinics under the Poliklinik CGI brand.
Sectors: Healthcare, Health Care Providers, Penny Stocks
Code: 0243
Website: https://www.cengild.com/
Related Links: Bursa | Annual Report | Announcement
Warrant Info:
No warrants listed
CENGILD Top Shareholdings
Updated on 2-Oct-2023
| Shareholder | % | Value (M) |
|---|---|---|
| Dato' Dr. Tan Huck Joo | 16.19% | 30.34 |
| Anne Marie Loh Foong Han | 9.64% | 18.07 |
| Emeritus Professor Dato' Dr Goh Khean Lee | 7.23% | 13.55 |
| Dr. Mohamed Akhtar Bin Mohamed Ditali Qureshi | 6.76% | 12.67 |
| Tan Kar Tek | 4.83% | 9.05 |
| Ramesh A/L K Gurunathan | 4.73% | 8.86 |
| Ong Siew Kuen | 3.87% | 7.25 |
| Medic Quest Sdn Bhd | 3.48% | 6.52 |
| Tony Tan Choon Keat | 3.28% | 6.15 |
| Transmetro Sdn Bhd | 2.81% | 5.27 |
| Tan Soon Wah | 1.59% | 2.98 |
| Tang Vee Mun | 1.57% | 2.94 |
| Koon Poh Keong | 1.56% | 2.92 |
| Lai Kwong Choy | 1.55% | 2.9 |
| Amanah Saham Sarawak | 1.32% | 2.47 |
| Great Eastern Group | 1.22% | 2.29 |
| Amir Azlan Zain | 0.67% | 1.26 |
| Tan Lim Tneah Kooi | 0.47% | 0.88 |
| Wang Phaik Mear | 0.46% | 0.86 |
| Kuok Su Sim | 0.42% | 0.79 |
| Yong Wan Yee | 0.41% | 0.77 |
| Pmb Shariah Equity Fund | 0.34% | 0.64 |
| Kang Hoo Chong | 0.32% | 0.6 |
| Foong Siew Ee | 0.31% | 0.58 |
| Lim Ban Hock | 0.27% | 0.51 |
| AIA Group | 0.26% | 0.49 |
| Wong Phooi Kheong | 0.26% | 0.49 |
| Barclays Capital Securities Ltd | 0.25% | 0.47 |
Frequently Asked Questions
Cengild Medical Berhad, incorporated in 2021 and headquartered in Kuala Lumpur, Malaysia, specializes in gastrointestinal and liver disease care, with a strong focus on obesity management and related specialties. Operating through its flagship Cengild G.I. Medical Centre, the company offers a wide range of services including gastroenterology, hepatology, gastrointestinal surgery, bariatric surgery, oncology, cardiology, urology, and ENT. It also provides diagnostic imaging, 24-hour emergency care, laboratory services, and outpatient treatments supported by multidisciplinary medical teams. Cengild’s operations are anchored by two main business segments, Consultant Services and Medical Management Services which delivered through state-of-the-art facilities, complemented by satellite primary care clinics under the Poliklinik CGI brand. The company is listed on Bursa Malaysia and operates in the Healthcare, Health Care Providers and Penny Stocks sectors.
Yes, CENGILD MEDICAL BERHAD is listed as Shariah-compliant.
The latest share price of CENGILD MEDICAL BERHAD is RM 0.225 updated on 23 January 2026 11:54.
As of now, CENGILD MEDICAL BERHAD has a market capitalization of 191M based on the latest financial data.
iSaham's technical analysis indicates that CENGILD MEDICAL BERHAD's support level is at RM 0.23 and its resistance level is at RM 0.25, based on moving averages and price patterns.
The 52-week high for CENGILD MEDICAL BERHAD is RM 0.24
CENGILD MEDICAL BERHAD's share price has decreased by -14.81% year-to-date, influenced by market trends and company performance.
CENGILD MEDICAL BERHAD declared a dividend of 0.97 sen for the year 2025-11-24. View more details on CENGILD MEDICAL BERHAD's Historical Dividends page.
The main shareholders of CENGILD MEDICAL BERHAD include Dato' Dr. Tan Huck Joo, Anne Marie Loh Foong Han and Emeritus Professor Dato' Dr Goh Khean Lee. View more on CENGILD MEDICAL BERHAD Top Shareholders page.
You can buy CENGILD MEDICAL BERHAD shares through any licensed online broker or trading platform registered with Bursa Malaysia. If you're new to investing, iSaham can help you open an account with M+ Online, one of Malaysia's leading brokers.
When you open your M+ account through the iSaham team, you can get iSaham Pro for free as a bonus offer.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.